Citations 1

Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation

JAMA Oncology | September 23, 2021 | Volume: 7 | Issue: 11 | Pages: 1669

10.1001/jamaoncol.2021.3836 | PMID 34554208